The National Agency for Food and Drug Administration and Control (NAFDAC) has raised alarm over the circulation of counterfeit batches of the emergency contraceptive pill, Postinor-2 (Levonorgestrel 0.75 mg), in Nigeria.
According to the agency, two falsified batches of the product were detected after a report from the Society for Family Health confirmed that it did not import the questionable consignments.
NAFDAC explained that the fake products can be identified through several errors on their packaging. The counterfeit packs carry spelling mistakes such as “Veify” instead of “Verify” on the PIN verification sticker and “Distnibuted in Nigeria” instead of “Distributed in Nigeria.” The fonts on the fake packs also appear smaller and less visible compared to the genuine ones.
- VIDEO: Woman Claiming to Be Chris Okafor’s Former Wife Makes Explosive Allegations
- I will not be vice-president to anybody ~ Peter Obi
- Israel recognises Somaliland as sovereign state
- 70-year-old Indian woman gives birth to her first child
- Ghanaian Prophet, Eboh Noah, Builds 8 Arks, Reveals God Has Warned Him That The World Will End On Christmas Day ~ Not By Fire, But By Another Global Flood.
- VIDEO: Pregnant wife bursts into tears as husband refuses to go beg neighbour Jollof rice
Details released by NAFDAC show that the original batch in circulation is T32458H, manufactured in February 2023 and expiring in February 2027. The fake products, however, bear batch numbers T36184B (August 2024–August 2028) and 332 (March 2023–February 2027).
The agency warned that the use of falsified Postinor-2 poses serious health risks, including contraceptive failure, harmful side effects from unknown substances, long-term reproductive complications, and, in extreme cases, death.
NAFDAC has directed all its zonal directors and state coordinators to intensify surveillance and mop up the counterfeit products from circulation. It also urged distributors, retailers, health workers, and consumers to remain vigilant and ensure medicines are obtained only from licensed pharmacies.
ORIGINAL PRODUCT (Type 1):
COUNTERFEIT PRODUCT (Type 1):
COUNTERFEIT PRODUCT (Type 2):
To better understand it, watch Aproko Doctor’s explanation below:
Suspected cases of counterfeit drugs should be reported via NAFDAC’s toll-free line 0800-162-3322, email ([email protected]), or through its e-reporting platforms on the agency’s website. Reports can also be filed using the Med-Safety mobile app, available on Android and iOS.
